Drug
Repository Corticotropin
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Injection Site Discolouration | 49 | 30.5 | 31.0 | signal |
| 2 | Injection Site Bruising | 208 | 20.3 | 21.9 | signal |
| 3 | Brain Fog | 27 | 14.3 | 14.4 | signal |
| 4 | Fluid Retention | 83 | 12.6 | 12.9 | signal |
| 5 | Increased Appetite | 25 | 10.2 | 10.3 | signal |
| 6 | Increased Tendency To Bruise | 12 | 10.0 | 10.1 | signal |
| 7 | Multiple Sclerosis Relapse | 88 | 9.8 | 10.1 | signal |
| 8 | Injection Site Pruritus | 79 | 9.1 | 9.4 | signal |
| 9 | Injection Site Mass | 39 | 8.1 | 8.2 | signal |
| 10 | Nerve Compression | 9 | 7.5 | 7.5 | signal |
| 11 | Systemic Lupus Erythematosus | 31 | 6.7 | 6.8 | signal |
| 12 | Injection Site Haemorrhage | 67 | 6.5 | 6.6 | signal |
| 13 | Swelling | 75 | 6.2 | 6.3 | signal |
| 14 | Injection Site Irritation | 9 | 5.5 | 5.5 | signal |
| 15 | Seasonal Allergy | 10 | 5.4 | 5.5 | signal |
| 16 | Injection Site Urticaria | 17 | 5.4 | 5.4 | signal |
| 17 | Immune System Disorder | 9 | 5.3 | 5.3 | signal |
| 18 | Feeling Jittery | 13 | 5.2 | 5.3 | signal |
| 19 | Peripheral Swelling | 104 | 5.2 | 5.4 | signal |
| 20 | Contraindicated Product Administered | 20 | 5.1 | 5.1 | signal |
| 21 | Injection Site Swelling | 50 | 5.1 | 5.2 | signal |
| 22 | Blood Pressure Abnormal | 13 | 5.0 | 5.1 | signal |
| 23 | Swelling Face | 42 | 5.0 | 5.0 | signal |
| 24 | Muscle Atrophy | 8 | 4.9 | 4.9 | signal |
| 25 | Eye Inflammation | 6 | 4.9 | 4.9 | signal |
| 26 | Injection Site Rash | 19 | 4.8 | 4.8 | signal |
| 27 | Intraocular Pressure Increased | 8 | 4.8 | 4.8 | signal |
| 28 | Illness | 62 | 4.7 | 4.8 | signal |
| 29 | Vitreous Floaters | 6 | 4.7 | 4.7 | signal |
| 30 | Product Dose Omission In Error | 16 | 4.6 | 4.6 | signal |
| 31 | Osteopenia | 9 | 4.5 | 4.5 | signal |
| 32 | Eye Discharge | 6 | 4.5 | 4.5 | signal |
| 33 | Limb Discomfort | 18 | 4.5 | 4.5 | signal |
| 34 | Central Nervous System Lesion | 8 | 4.4 | 4.5 | signal |
| 35 | Spinal Operation | 7 | 4.4 | 4.5 | signal |
| 36 | Aphonia | 8 | 4.4 | 4.4 | signal |
| 37 | Mass | 8 | 4.4 | 4.4 | signal |
| 38 | Insomnia | 151 | 4.4 | 4.6 | signal |
| 39 | Injection Site Pain | 171 | 4.3 | 4.6 | signal |
| 40 | Product Dose Omission Issue | 160 | 4.3 | 4.5 | signal |
| 41 | Blood Glucose Increased | 103 | 4.2 | 4.3 | signal |
| 42 | Blood Glucose Abnormal | 10 | 4.2 | 4.2 | signal |
| 43 | Weight Increased | 120 | 4.1 | 4.3 | signal |
| 44 | Injection Site Warmth | 11 | 4.1 | 4.1 | signal |
| 45 | Hemiparesis | 9 | 4.1 | 4.1 | signal |
| 46 | Eye Pain | 29 | 4.0 | 4.1 | signal |
| 47 | Uveitis | 7 | 4.0 | 4.0 | signal |
| 48 | Thirst | 9 | 3.9 | 3.9 | signal |
| 49 | Carpal Tunnel Syndrome | 7 | 3.8 | 3.8 | signal |
| 50 | Rheumatoid Arthritis | 56 | 3.8 | 3.9 | signal |
| 51 | Injection Site Erythema | 61 | 3.8 | 3.9 | signal |
| 52 | Injection Site Discomfort | 5 | 3.7 | 3.7 | signal |
| 53 | Irritability | 29 | 3.7 | 3.7 | signal |
| 54 | Immunodeficiency | 7 | 3.7 | 3.7 | signal |
| 55 | Laboratory Test Abnormal | 14 | 3.7 | 3.7 | signal |
| 56 | Insurance Issue | 7 | 3.6 | 3.6 | signal |
| 57 | Mood Swings | 15 | 3.6 | 3.6 | signal |
| 58 | Blood Pressure Increased | 72 | 3.6 | 3.7 | signal |
| 59 | Bipolar Disorder | 5 | 3.5 | 3.5 | signal |
| 60 | Head Discomfort | 8 | 3.5 | 3.5 | signal |
| 61 | Inappropriate Schedule Of Product Administration | 79 | 3.4 | 3.5 | signal |
| 62 | Hunger | 6 | 3.4 | 3.4 | signal |
| 63 | Multiple Sclerosis | 21 | 3.4 | 3.4 | signal |
| 64 | Posterior Reversible Encephalopathy Syndrome | 4 | 3.2 | 3.2 | signal |
| 65 | Skin Discolouration | 19 | 3.2 | 3.2 | signal |
| 66 | Dry Eye | 20 | 3.2 | 3.2 | signal |
| 67 | Knee Operation | 4 | 3.2 | 3.2 | no signal |
| 68 | Muscle Spasticity | 5 | 3.1 | 3.1 | signal |
| 69 | Tooth Extraction | 5 | 3.1 | 3.1 | signal |
| 70 | Therapeutic Response Shortened | 12 | 2.9 | 2.9 | signal |
| 71 | Eye Haemorrhage | 5 | 2.9 | 2.9 | signal |
| 72 | Thinking Abnormal | 7 | 2.9 | 2.9 | signal |
| 73 | Therapy Cessation | 19 | 2.9 | 2.9 | signal |
| 74 | Surgery | 21 | 2.8 | 2.8 | signal |
| 75 | Glycosylated Haemoglobin Increased | 9 | 2.7 | 2.8 | signal |
| 76 | Blindness Unilateral | 5 | 2.7 | 2.7 | no signal |
| 77 | Impaired Driving Ability | 4 | 2.7 | 2.7 | no signal |
| 78 | Blindness | 14 | 2.6 | 2.7 | signal |
| 79 | Underdose | 24 | 2.5 | 2.5 | signal |
| 80 | Injection Site Induration | 4 | 2.4 | 2.4 | no signal |
| 81 | Knee Arthroplasty | 6 | 2.2 | 2.2 | no signal |
| 82 | Acne | 14 | 1.4 | 1.4 | no signal |
| 83 | Injection Site Reaction | 11 | 1.2 | 1.2 | no signal |
| 84 | Menstruation Irregular | 3 | 0.9 | 0.9 | no signal |